# NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

> **NCT00315432** · PHASE2 · COMPLETED · sponsor: **Ortho Biotech Products, L.P.** · enrollment: 91 (actual)

## Conditions studied

- Hepatitis C
- HIV
- Anemia

## Interventions

- **DRUG:** Pegylated Interferon and Ribavirin

## Key facts

- **NCT ID:** NCT00315432
- **Lead sponsor:** Ortho Biotech Products, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2003-11
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315432, "NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00315432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*